Australia's EBR Systems rises on first patient enrolment in CRT study

EBR Systems

12/12/2025 24:25

** Shares of EBR Systems EBR.AX advance as much as 5.52% to A$0.955, their highest point since December 4

** The medtech co reportsfirst patient enrolment and implant in a totally leadless cardiac resynchronization therapy (CRT) study, which could "meaningfully expand" its addressable market

** Adds that the study marks a key milestone as it tests WiSE for a potential first-line heart failure therapy

** Stock down 9.3% YTD, including the day's moves

(Reporting by Kumar Tanishk in Bengaluru)

((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))